BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8958985)

  • 1. Effects of hypertension and propranolol upon aneurysm expansion in the Anidjar/Dobrin aneurysm model.
    Ricci MA; Slaiby JM; Gadowski GR; Hendley ED; Nichols P; Pilcher DB
    Ann N Y Acad Sci; 1996 Nov; 800():89-96. PubMed ID: 8958985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of aortic aneurysms is reduced by propranolol in a hypertensive rat model.
    Slaiby JM; Ricci MA; Gadowski GR; Hendley ED; Pilcher DB
    J Vasc Surg; 1994 Aug; 20(2):178-83. PubMed ID: 8040940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension accelerates the growth of experimental aortic aneurysms.
    Gadowski GR; Ricci MA; Hendley ED; Pilcher DB
    J Surg Res; 1993 May; 54(5):431-6. PubMed ID: 8361169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade.
    Gadowski GR; Pilcher DB; Ricci MA
    J Vasc Surg; 1994 Apr; 19(4):727-31. PubMed ID: 7909340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a trial to evaluate the effect of propranolol upon abdominal aortic aneurysm expansion.
    Ricci MA; Pilcher DB; McBride R
    Ann N Y Acad Sci; 1996 Nov; 800():252-3. PubMed ID: 8959004
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-CD 18 monoclonal antibody slows experimental aortic aneurysm expansion.
    Ricci MA; Strindberg G; Slaiby JM; Guibord R; Bergersen LJ; Nichols P; Hendley ED; Pilcher DB
    J Vasc Surg; 1996 Feb; 23(2):301-7. PubMed ID: 8637107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms.
    Lindholt JS; Henneberg EW; Juul S; Fasting H
    Int Angiol; 1999 Mar; 18(1):52-7. PubMed ID: 10392481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of endovascular graft exclusion and drug therapy in AAA with hypertension or hyperglycemia.
    Wang D; Qu B; He T
    Minerva Cardioangiol; 2017 Aug; 65(4):348-354. PubMed ID: 28146143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variables that affect the expansion rate and rupture of abdominal aortic aneurysms.
    Cronenwett JL
    Ann N Y Acad Sci; 1996 Nov; 800():56-67. PubMed ID: 8958982
    [No Abstract]   [Full Text] [Related]  

  • 10. Nifedipine attenuation of abdominal aortic aneurysm in hypertensive and non-hypertensive mice: Mechanisms and implications.
    Miao XN; Siu KL; Cai H
    J Mol Cell Cardiol; 2015 Oct; 87():152-9. PubMed ID: 26254182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension accelerated experimental abdominal aortic aneurysm through upregulation of nuclear factor kappaB and Ets.
    Shiraya S; Miwa K; Aoki M; Miyake T; Oishi M; Kataoka K; Ohgi S; Ogihara T; Kaneda Y; Morishita R
    Hypertension; 2006 Oct; 48(4):628-36. PubMed ID: 16940214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with small abdominal aortic aneurysm expansion rate.
    Bhak RH; Wininger M; Johnson GR; Lederle FA; Messina LM; Ballard DJ; Wilson SE;
    JAMA Surg; 2015 Jan; 150(1):44-50. PubMed ID: 25389641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical management of small abdominal aortic aneurysms.
    Baxter BT; Terrin MC; Dalman RL
    Circulation; 2008 Apr; 117(14):1883-9. PubMed ID: 18391122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of an effective drug therapy for abdominal aortic aneurysm.
    Golledge J; Moxon JV; Singh TP; Bown MJ; Mani K; Wanhainen A
    J Intern Med; 2020 Jul; 288(1):6-22. PubMed ID: 31278799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinaemia is associated with the rate of abdominal aortic aneurysm expansion.
    Halazun KJ; Bofkin KA; Asthana S; Evans C; Henderson M; Spark JI
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):391-4; discussion 395-6. PubMed ID: 17164089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth predictors and prognosis of small abdominal aortic aneurysms.
    Schlösser FJ; Tangelder MJ; Verhagen HJ; van der Heijden GJ; Muhs BE; van der Graaf Y; Moll FL;
    J Vasc Surg; 2008 Jun; 47(6):1127-33. PubMed ID: 18440183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol for small abdominal aortic aneurysms: results of a randomized trial.
    Propanolol Aneurysm Trial Investigators
    J Vasc Surg; 2002 Jan; 35(1):72-9. PubMed ID: 11802135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible role of an endogenous opioid in the antihypertensive action of propranolol in spontaneously hypertensive rats.
    Farsang C; Ramirez-Gonzalez MD; Tchakarov L; Kunos G
    Acta Physiol Hung; 1983; 62(2):167-75. PubMed ID: 6670566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and biochemical characteristics of the aorta in the WKY, SHR, WKHT, and WKHA rat strains.
    Ricci MA; Slaiby JM; Hendley ED; Stirewalt W; Cloutier L; Nichols P; Evans JN
    Ann N Y Acad Sci; 1996 Nov; 800():121-30. PubMed ID: 8958987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of statins on the expansion rate and rupture risk of abdominal aortic aneurysms.
    VAN KUIJK JP; FLU WJ; WITTEVEEN OP; VOUTE M; BAX JJ; POLDERMANS D
    J Cardiovasc Surg (Torino); 2009 Oct; 50(5):599-609. PubMed ID: 19741575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.